(Q42227512)

19 October 2017

title

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. (English)

1 reference

cost-effectiveness analysis

19 October 2017

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Giuseppe Cabibbo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Giuseppe Cabibbo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Antonio Craxì

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Fabio Macaluso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Antonella Plaia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Raffaele Bruno

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Marco Enea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Antonio Gasbarrini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Calogero Cammà

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

WEF Study Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

1 April 2014

1 reference

19 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1692-1705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

Global burden of disease (GBD) for hepatitis C.

12 June 2020

cites work

1 reference

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

21 January 2018

1 reference

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

21 January 2018

1 reference

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

21 January 2018

1 reference

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

21 January 2018

1 reference

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

21 January 2018

1 reference

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

21 January 2018

1 reference

Relaxed phylogenetics and dating with confidence

21 January 2018

1 reference

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching

21 January 2018

1 reference

Histology predicts cirrhotic evolution of post transplant hepatitis C

21 January 2018

1 reference

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

21 January 2018

1 reference

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population

21 January 2018

1 reference

Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients

21 January 2018

1 reference

New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis

21 January 2018

1 reference

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

21 January 2018

1 reference

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

21 January 2018

1 reference

Calculating QALYs, comparing QALY and DALY calculations.

21 January 2018

1 reference

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

21 January 2018

1 reference

Impact of a sustained virological response on the long-term outcome of hepatitis C.

21 January 2018

1 reference

Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse

21 January 2018

1 reference

Empirically calibrated model of hepatitis C virus infection in the United States

21 January 2018

1 reference

Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States

21 January 2018

1 reference

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

21 January 2018

1 reference

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

21 January 2018

1 reference

Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

21 January 2018

1 reference

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Health technology assessment implementation: the politics of ethics

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691835%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference